EFFECTIVENESS, SAFETY AND INCREMENTAL COSTS OF PROACTIVE THERAPEUTIC DRUG MONITORING OF INFLIXIMAB IN A REAL-LIFE COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS

Zuzana Zelinkova  1     Barbora Kadlečková  1     Anna Lipovska  1     Dusan Podmanicky  1    
1 Nemocnica Bory - Penta Hospitals, Bratislava, Slovakia

Topic
IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing